$1.38
9.21% yesterday
Nasdaq, Jun 13, 10:08 pm CET
ISIN
IL0011050551
Symbol
EVGN
Sector
Industry

Evogene Ltd Stock price

$1.38
+0.16 13.11% 1M
+0.01 0.73% 6M
-0.49 26.20% YTD
-5.18 78.97% 1Y
-9.02 86.73% 5Y
-91.42 98.51% 10Y
-25.62 94.89% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.14 9.21%
ISIN
IL0011050551
Symbol
EVGN
Sector
Industry

Key metrics

Market capitalization $10.14m
Enterprise Value $13.25m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.96
P/S ratio (TTM) P/S ratio 1.50
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -26.33%
Revenue (TTM) Revenue $6.77m
EBIT (operating result TTM) EBIT $-22.44m
Free Cash Flow (TTM) Free Cash Flow $-21.38m
Cash position $9.85m
EPS (TTM) EPS $-2.23
P/S forward 1.56
EV/Sales forward 2.04
Short interest 1.77%
Show more

Is Evogene Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Evogene Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Evogene Ltd forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Evogene Ltd forecast:

Buy
100%

Financial data from Evogene Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
6.77 6.77
26% 26%
100%
- Direct Costs 3.99 3.99
138% 138%
59%
2.78 2.78
63% 63%
41%
- Selling and Administrative Expenses 10 10
1% 1%
150%
- Research and Development Expense 15 15
28% 28%
222%
-20 -20
3% 3%
-296%
- Depreciation and Amortization 2.41 2.41
9% 9%
36%
EBIT (Operating Income) EBIT -22 -22
4% 4%
-331%
Net Profit -15 -15
29% 29%
-225%

In millions USD.

Don't miss a Thing! We will send you all news about Evogene Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evogene Ltd Stock News

Neutral
PRNewsWire
4 days ago
The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications REHOVOT, Israel , June 10, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and development, today announced...
Neutral
Seeking Alpha
23 days ago
Evogene Ltd. (NASDAQ:EVGN ) Q1 2025 Earnings Conference Call May 21, 2025 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Operator Welcome to Evogene's First Quarter 2025 Results Conference Call.
Neutral
PRNewsWire
24 days ago
Conference call and webcast: today, May 21, 2025, 9:00 am ET Financial Highlights: In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million in the first quarter of 2024. The first quarter of 2024 revenues included license fee payments totaling $3.5 million - $2.5 million from Lavie Bio's license fee under its collaboration with Corteva...
More Evogene Ltd News

Company Profile

Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities. The company was founded by Amir Barzilay and Hagai Karchi in 2002 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Ofer Haviv
Employees 117
Founded 1999
Website evogene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today